I believe the demand for plasma products is in strong demand and growing, along with CSL having its own vertically integrated collection network creates a wide moat/ a large barrier to entry for new players. This along with its R&D (and the fact they opex R&D expense) pipeline and vaccine business creates a great position for future earnings.
Time to do a 5 for 1 split of csl shares, page-15
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.26 |
Change
-1.400(0.46%) |
Mkt cap ! $145.3B | |||
| Open | High | Low | Value | Volume |
| $303.31 | $303.47 | $299.56 | $148.6M | 498.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 276 | $300.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.34 | 1250 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |